• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉血管成形术后再狭窄:临床研究的新标准。

Restenosis after coronary angioplasty: new standards for clinical studies.

作者信息

Beatt K J, Serruys P W, Hugenholtz P G

机构信息

Thoraxcenter, Erasmus University, Rotterdam, The Netherlands.

出版信息

J Am Coll Cardiol. 1990 Feb;15(2):491-8. doi: 10.1016/s0735-1097(10)80081-6.

DOI:10.1016/s0735-1097(10)80081-6
PMID:2299089
Abstract

With the high initial success rates for coronary angioplasty that are reported regularly, it has become increasingly difficult to demonstrate methods or techniques that are able to provide more beneficial early results than can be achieved by conventional angioplasty. On the other hand, the incidence of late restenosis has remained much the same over the 10 years that angioplasty has been part of clinical practice, and there is still no proved intervention that modifies the restenosis process. Therefore, the problem of restenosis has assumed increasing relevance in determining the clinical value of coronary angioplasty and, accordingly, studies that address the problem of restenosis need to become more exacting. Although numerous articles have addressed the problem of restenosis in the clinical setting, many defining certain factors associated with restenosis and possible interventions to reduce the incidence of restenosis, there is surprisingly little consensus. Most of the discrepancies can be attributed to three factors: 1) the selection of patients, 2) the method of analysis, and 3) the definition of restenosis employed. This review shows how these three factors influence the outcome and conclusions of restenosis studies.

摘要

随着冠状动脉血管成形术经常报告的高初始成功率,越来越难以证明哪些方法或技术能够提供比传统血管成形术更有益的早期结果。另一方面,在血管成形术成为临床实践一部分的10年里,晚期再狭窄的发生率基本保持不变,而且仍然没有经过证实的干预措施能够改变再狭窄过程。因此,再狭窄问题在确定冠状动脉血管成形术的临床价值方面变得越来越重要,相应地,解决再狭窄问题的研究需要变得更加严格。尽管有许多文章探讨了临床环境中的再狭窄问题,许多文章确定了与再狭窄相关的某些因素以及降低再狭窄发生率的可能干预措施,但令人惊讶的是,几乎没有达成共识。大多数差异可归因于三个因素:1)患者的选择,2)分析方法,3)所采用的再狭窄定义。这篇综述展示了这三个因素如何影响再狭窄研究的结果和结论。

相似文献

1
Restenosis after coronary angioplasty: new standards for clinical studies.冠状动脉血管成形术后再狭窄:临床研究的新标准。
J Am Coll Cardiol. 1990 Feb;15(2):491-8. doi: 10.1016/s0735-1097(10)80081-6.
2
Restenosis following coronary angioplasty.冠状动脉血管成形术后再狭窄
Am Heart J. 1990 Feb;119(2 Pt 1):357-68. doi: 10.1016/s0002-8703(05)80028-6.
3
Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilation for a first restenosis.
J Am Coll Cardiol. 1992 Oct;20(4):845-8. doi: 10.1016/0735-1097(92)90182-m.
4
Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis.同一部位多次经皮腔内冠状动脉成形术后的再狭窄率。一项对因第二次再狭窄接受第三次血管成形术的连续患者进行的定量血管造影研究。
Circulation. 1993 Sep;88(3):969-74. doi: 10.1161/01.cir.88.3.969.
5
Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy.
J Am Coll Cardiol. 1993 Jan;21(1):15-25. doi: 10.1016/0735-1097(93)90712-a.
6
Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.经皮冠状动脉介入治疗器械再狭窄倾向的差异。球囊血管成形术、定向旋切术、支架植入术和准分子激光血管成形术的定量血管造影比较。CARPORT、MERCATOR、MARCATOR、PARK和BENESTENT试验组。
Eur Heart J. 1995 Oct;16(10):1331-46. doi: 10.1093/oxfordjournals.eurheartj.a060740.
7
Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty.
Circulation. 1995 Feb 15;91(4):968-72. doi: 10.1161/01.cir.91.4.968.
8
Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.评估冠状动脉支架置入术作为有症状单支冠状动脉疾病治疗方法的潜在成本效益。采用决策分析模型。
Circulation. 1994 Apr;89(4):1859-74. doi: 10.1161/01.cir.89.4.1859.
9
Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.冠状动脉球囊血管成形术后再狭窄的预防:氟伐他汀血管成形术再狭窄(FLARE)试验的原理与设计。FLARE研究组
Am J Cardiol. 1994 May 26;73(14):50D-61D. doi: 10.1016/0002-9149(94)90633-5.
10
Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.糖尿病患者的再狭窄率:天然冠状动脉血管中冠状动脉支架置入术与球囊血管成形术的比较
Circulation. 1997 Sep 2;96(5):1454-60. doi: 10.1161/01.cir.96.5.1454.

引用本文的文献

1
Carotid Artery Atherosclerotic Profile as Risk Predictor for Restenosis After Coronary Stenting.颈动脉粥样硬化特征作为冠状动脉支架置入术后再狭窄的风险预测指标。
Arq Bras Cardiol. 2021 Apr;116(4):727-733. doi: 10.36660/abc.20190650.
2
Impact of post-dilatation with a focal expanding balloon for optimization of intracoronary stenting.使用聚焦扩张球囊进行后扩张对优化冠状动脉内支架置入的影响。
Heart Vessels. 2007 May;22(3):152-7. doi: 10.1007/s00380-006-0952-y. Epub 2007 May 21.
3
Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.
对有再狭窄高风险的患者在冠状动脉血管成形术后进行维拉帕米治疗。
Br Heart J. 1994 Mar;71(3):254-60. doi: 10.1136/hrt.71.3.254.
4
Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty.地塞米松局部给药预防大鼠球囊血管成形术模型中新生内膜增生
J Clin Invest. 1994 Mar;93(3):1243-9. doi: 10.1172/JCI117078.
5
Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).血管成形术后预防再狭窄的药理学方法。寻找圣杯?(第二部分)
Drugs. 1993 Aug;46(2):249-62. doi: 10.2165/00003495-199346020-00003.
6
Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cells in vitro.纤连蛋白的表达与U937细胞在体外对迁移的牛主动脉内皮细胞的黏附相关。
Am J Pathol. 1993 Jul;143(1):173-80.
7
Does it matter how coronary projections are combined to assess restenosis following PTCA?冠状动脉投影如何组合以评估经皮冠状动脉腔内血管成形术(PTCA)后的再狭窄是否重要?
Int J Card Imaging. 1995 Sep;11(3):145-9. doi: 10.1007/BF01143103.
8
Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo.新型非抗凝肝素衍生物对体外和体内血管平滑肌细胞的抗增殖作用。
Am J Pathol. 1991 Dec;139(6):1501-9.
9
Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography.冠状动脉血管成形术后再狭窄:基于定量血管造影术的新比较方法建议
Br Heart J. 1992 Oct;68(4):417-24. doi: 10.1136/hrt.68.10.417.